Joshua M Fine
CIK 1779940 · Chief Operating Officer · last filed 2025-09-05
Joshua M Fine is a Chief Operating Officer who has filed 9 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for RFL.WS, was dated Sep 5, 2025. Across all open-market trades the lifetime net is +$370, making them a net buyer over the disclosed history. 2 SEC filings were submitted jointly with Rafael Holdings, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CYTHW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WILTON, CT 06897
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Rafael Holdings, Inc. (RFL.WS) Delisted | Chief Operating Officer | 9,380 | $0.01 | $133 | $0 | 1 | 2025-09-05 |
| Cyclo Therapeutics, Inc. (CYTHW) Delisted | Chief Financial Officer | 16,900 | $0.03 | $541 | $370 | 6 | 2024-06-05 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-05 | Rafael Holdings, Inc. (RFL.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-09 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-02 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-30 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-30 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Buy (P) | +50 | $370 | EDGAR |
| 2021-01-25 | Cyclo Therapeutics, Inc. (CYTHW) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2020-11-25 | — | Buy (P) | +25,000 | $1.9K | |
| 2019-09-30 | — | Grant (A) | +50,000 | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.